'Benign erythrocytosis' and other familial and congenital polycythemias

European Journal of Haematology

Volumn 57, Issue 4, 1996, Pages 263-268

  Prchal, Josef T ^a   Sokol, Lubomir ^a  

^a University of Alabama at Birmingham ^*  (United States)

Author keywords

differential diagnosis; erythrocytosis; erythropoiesis; erythropoietin; erythropoietin receptor; oxygen sensing; primary and secondary polycythemias

Indexed keywords

ERYTHROPOIETIN;

ERYTHROCYTOSIS; FAMILIAL DISEASE; GENE MUTATION; HUMAN; POLYCYTHEMIA; PRIORITY JOURNAL; REVIEW;

EID: 0029849911     PISSN: 09024441     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0609.1996.tb01376.x     Document Type: Review

References (35)

1. KRANTZ SB. Erythropoietin. 1991: Blood 77: 419.
2. SEMENZA GL, WANG GL. A nuclear factor induced by hypoxia via de novo protein synthesis binds to the human erythropoietin gene enhancer at a site required for transcriptional activation. Mol Cell Biol 1992: 12: 5447.
3. D'ANDREA AD, LODISH HF, WONG GG. Expression cloning of murine erythropoietin receptor. Cell 1989: 57: 277.
4. WITTHUHN BA, QUELLE FW, SILVENNOINEN O, et al. JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin. Cell 1993: 74: 227-238.
5. D'ANDREA AD, YOSHIMURA A, YOUSSOUFIAN H, ZON L, Koo J, LODISH H. The cytoplasmic region of the erythropoietin receptor contains non-overlapping positive and negative growth regulatory domains. Mol Cell Biol 1991: 11: 1980.
6. YI T, ZHANG J, MIURA O, IHLE JN. Hematopoietic cell phosphatase associates with erythropoietin (Epo) receptor after Epo-induced receptor tyrosine phosphorylation: identification of potential binding sites. Blood 1995: 85: 87-95.
7. KLINGMULLER U, LORENZ U CANTLEY LC, NEEL BG, LODISH HF. Specific Recruitment of SH-PTP1 to the erythropoietin receptor causes inactivation of JAK2 and termination of proliferative signals. Cell 1995: 80: 729-738.
8. SOKOL L, PRCHAL JT. Two microsatellite repeat polymorphisms in the EPOR gene. Hum Mol Genet 1994: 3: 219.
9. BERLIN NI. Diagnosis and classification of the polycythemias. Semin Hematol 1975: 12: 339-351.
10. ADAMSON JW. Familial polycythemia. Semin Hematol 1975: 12: 383.
11. LICHTMAN MA, MURPHY MS, ADAMSON JW. Detection of mutant hemoglobins with altered affinity for oxygen. A simplified technique. Ann Intern Med 1976: 84: 517.
12. ERSLEV AJ. Erythrocyte disorders - erythrocytosis. In: WILLIAMS WJ, BEUTLER E, ERSLEV AJ, LICHTMAN MA, eds. Hematology. New York, NY: McGraw/Hill, 1990: 705.
13. WHITCOMBE WH, PESCHLE C, MOORE M, NITSCHKE R, ADAMSON JW. Congenital erythrocytosis: a new form associated with an erythropoietin-dependent mechanism. Br J Haematol 1980: 44: 17-24.
14. PRCHAL, JT, GOLDWASSER E, SOKOL L, PRCHAL JF, KIDDER WR, GUAN Y. Blood 1993: 82: 884a.
15. SOKOL L, KRALOVICS R, REN S, LUHOVY M, PRCHAL JF, PRCHAL JT. Secondary polycythemia with putative defect in HIF-1 transcription activation pathway. Blood 1995: 86: 312a.
16. PRCHAL JT, CRIST WM, GOLDWASSER E, PERRINE G, PRCHAL JF. Autosomal dominant polycythemia. Blood 1985: 66: 1208.
17. EMANUEL PD, EAVES CJ, BROUDY VC, et al. Hereditary polycythemia in three unrelated families. Blood 1992: 79: 3019.
18. JUVONEN E, IKKALA E, FYHRQUIST F, RUUTU T. Autosomal dominant erythrocytosis caused by increased sensitivity to erythropoietin. Blood 1991: 78: 3066.
19. PRCHAL JF, AXELRAD AA. Bone-marrow responses in polycythemia vera. N Engl J Med 1974: 289: 132.
20. SOKOL, L, PRCHAL JF, D'ANDREA A, RADO TA, PRCHAL JT. Mutation in the negative regulatory element of the erythropoietin gene in the negative regulatory element of the erythropoeitin receptor gene in a case of sporadic primary polycythemia. Exp Hematol 1994: 22: 447.
21. DE LA CHAPELLE A, TRASKELIN AL, JUVONEN E. Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. Proc Nat Acad Sci USA 1993: 90: 4495.
22. SOKOL L, PRCHAL JF, PRCHAL JT. Primary familial and congenital polycythemia is a heterogeneous disorder. Lancet 1993: 342: 115-116.
23. KRALOVICS R, SOKOL L, TZE L, GUAN Y, PRCHAL JF, PRCHAL JT. Absence of polycythemia phenotype in a child in PFCP family with EPO receptor mutation. Blood 1995: 86: 18a.
24. KRALOVICS R, TZE L, GUAN Y, et al. Two unique EPOR mutations associated with primary familial and congenital polycythemias. Blood 1995: 86: 18a.
25. LE COUEDIC J-P, MITJAVILA M-T, VILLEVAL J-L, et al. Punctual mutation of the erythropoietin receptor (EPOR) is a rare event in human erythroid malignancies. Blood 1994: 84: 206a.
26. SOKOL, L, LUHOVY, M, GUAN Y, PRCHAL, JF, SEMENZA GL, PRCHAL, JT. Primary familial polycythemia: a frameshift mutation in the erythropoietin receptor gene and increased sensitivity of erythroid progenitors to erythropoietin. Blood 1995: 86: 15-22.
27. KRALOVICS R, TZE L, GUAN Y, BROWSON E, SOKOL L, PRCHAL JT. Absence of linkage between polycythemia phenotype and EPO receptor mutation in a large polycythemic family. Blood 1995: 86: 18a.
28. PENTA K, SAWYER T. Erythropoietin induces the tyrosine phosphorylation, nuclear translocation, and DNA binding of STAT1 and STATS in erythroid cells. J Biol Chem 1995: 270: 31282-31287.
29. HANRATTY WP, DEAROLF CR. The Drosophila tumorouslethal hematopoietic oncogene is a dominant mutation in the hopscotch locus. Mol Gen Genet 1993: 238: 33-37.
30. PRCHAL JT, SEMENZA GL, PRCHAL J, SOKOL L. Familial polycythemia. Science 1995: 268: 1831-1832.
31. ANAGNOSTOU, A, LIU Z, STEINER, M, et al. Erythropoietin receptor mRNA expression in human endothelial cells. Proc Natl Acad Sci USA 1994: 91: 3974-3978.
32. MASUDA S, NAGAO M, TAKAHATA K, et al. Functional erythropoietin receptor of the cells with neural characteristics. J Biol Chem 1993: 268: 11208-11216.
33. POLYAKOVA LA. Familial hereditary erythrocytosis [in Russian], Probl Gematol 1974: 10: 30.
34. DMITRIEVA MG, TOKAREV UN. Hereditary erythrocytosis. Sov Med Rev C Hematol 1990: 2B: 121.
35. SERGEEVA A, SOKOL L, PRCHAL JF, TOKAREV Y, GORDEUK V, PRCHAL JT. Mid-Volga (Chuvash) type of congenital polycythemia. Blood 1993: 82: 556a.